Human growth hormone therapy in hypopituitarism due to tuberculous meningitis.
D000293:Adolescent; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D001786:Blood Glucose; D001827:Body Height; D002114:Calcinosis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003919:Diabetes Insipidus; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000627:therapeutic use*; D006429:Hemiplegia; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy* / Q000209:etiology; D007538:Isoniazid / Q000627:therapeutic use; D009765:Obesity / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000150:complications* / Q000188:drug therapy; D014667:Vasopressins / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D001786:Blood Glucose; D014667:Vasopressins; D011718:Pyrazinamide; D013006:Growth Hormone; D007538:Isoniazid; D011241:Prednisone; D013307:Streptomycin